Free Delivery Over $100
|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Carlo Masserdotti (IDEXX Laboratories, Brescia, Italy)Publisher: John Wiley and Sons Ltd Imprint: Wiley-Blackwell Dimensions: Width: 15.80cm , Height: 1.80cm , Length: 23.10cm Weight: 0.590kg ISBN: 9781119895541ISBN 10: 1119895545 Pages: 288 Publication Date: 16 September 2023 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In stock  We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of Contents1 Before the analysis. Rules for interpretation of hepatic cytology 1.1 The rules for cytological diagnosis of hepatic diseases 1.1.1 Rule 1 1.1.2 Rule 2 1.1.3 Rule 3 1.1.4 Rule 4 1.1.5 Rule 5 1.1.6 Rule 6 1.1.7 Rule 7 1.2 Diagnostic approach to liver disease 1.2.1 Clinical and anamnestic signs 1.2.2 Hematochemical investigations 1.2.2.1 Pathological bases of liver damage 1.2.2.2 Diagnosis of liver damage 1.2.2.3 Useful enzymes for the recognition of damage to the hepatocyte and cholangiocyte 1.2.2.4 Liver failure diagnosis 1.2.2.5 Parameters of liver failure 1.2.3 Ultrasonographic investigation 1.2.4 Cytological and histopathological investigation 1.2.4.1 Sample collection 1.2.4.2 Cytological approach to hepatic diseases 1.3 To rimember 2 Normal Histology and Cytology of the liver 2.1 Normal liver histology 2.2 Normal cytology of the liver 2.2.1 Hepatocytes 2.2.2 Kupffer cells 2.2.3 Stellate cells 2.2.4 Cholangiocytes (biliary cells) 2.2.6 Hepatic mast cells 2.2.7 Hematopoietic cells 2.2.8 Mesothelial cells 2.3 To rimember 3 Non-specific and reversible hepatocellular damage 3.1 Accumulation of water 3.2 Accumulation of glycogen 3.3 Accumulation of lipids 3.4 Accumulation of bilirubin and bile salts 3.5 Hyperplasia of stellate cells 3.6 Regenerative changes 3.7 To rimember 4 Intra and extra-cytoplasmic pathological accumulation 4.1 Pathological intracytoplasmic accumulation 4.1.1. Lipofuscin 4.1.2 Copper 4.1.3 Iron and hemosiderin 4.1.4 Protein droplets 4.1.5 Cytoplasmic granular eosinophilic material 4.1.6. Hepatic lysosomal storage disorders 4.2 Pathological extracytoplasmic accumulations 4.2.1 Bile 4.2.2 Amyloid 4.3 To remember 5 Irreversible hepatocellular damage 5.1 Necrosis 5.2 Apoptosis 5.3 To remember 6 Inflammation 6.1 Presence of neutrophilic granulocyte 6.2 Presence of eosinophilic granulocytes 6.3 Presence of lymphocytes and plasmacells 6.4 Presence of macrophages 6.5 Presence of mast cells 6.6 To remember 7 Nuclear inclusions 7.1 “Brick” inclusions 7.2 Glycogen pseudo-inclusions 7.3 Lead inclusions 7.4 Viral inclusions 7.5 To remember 8 Cytological features of liver fibrosis 8.1 Cytological features of liver fibrosis 8.2 To remember 9 Cytological Features of biliary diseases 9.1 General features of biliary diseases 9.2 Cytological features of some specific biliary diseases 9.2.1 Acute and chronic cholestasis 9.2.2 Acute cholangitis 9.2.3 Chronic cholangitis 9.2.4 Lymphocytic cholangitis 9.3 To rimember 10 Bile and gallbladder diseases 10.1 Bactibilia and septic cholecystitis 10.2 Epithelial hyperplasia 10.3 Gallbladder mucocele 10.4 Limy bile syndrome 10.5 Biliary sludge 10.6 Neoplastic diseases of gallbladder 10.7 Other gallbladder diseases 10.8 To remember 11 Ethiological agents 11.1 Virus 11.2 Bacteria 11.3 Protozoa 11.4 Fungi 11.5 Parasites 11.6 To remember 12 Neoplastic lesions of the hepatic parenchyma 12. 2 Nodular lesions of epithelial origins 12.2.1 Nodular hyperplasia 12.2.2 Hepatocellular adenoma 12.2.3 Hepatocellular carcinoma 12.2.4 Cholangioma 12.2.5 Cholangiocellular carcinoma 12.2.6 Other nodular lesions of biliary origins 12.2.7 Hepatic carcinoid 12.2.8 Hepatoblastoma 12.3 Nodular lesions of mesenchymal origin 12.3.1 Malignant mesenchymal neoplasms 12.4 Nodular lesions of hematopoietic origin 12.4.1. Myelolipoma 12.4.2. Large-cell hepatic lymphoma 12.4.3 Small cell lymphoma 12.4.4. LGL lymphoma 12.4.5 Epitheliotropic lymphoma 12.4.6 Other types of hepatic lymphoma 12.4.7. Malignant histiocytic neoplasms 12.4.8. Mast cell tumor 12.4.9 Hepatic splenosis 12.5 Liver metastasis 12.6 Criteria for the selection of sampling methods of liver nodular lesions 12.7 To rememberReviewsAuthor InformationCarlo Masserdotti, DVM, Dipl ECVCP, Spec Bioch Clin IAT, Consultant, Anatomic and Clinical Pathology, IDEXX Laboratories, Brescia, Italy. Tab Content 6Author Website:Countries AvailableAll regions |
||||
